Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-17

Clinical Trial Update: Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and preliminary activity of Sunitinib in combination with the FOLFOX chemotherapy regimen in patients with colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)
  • Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2010-08-17